Clare Fisher
About Clare Fisher
Clare Fisher is the Senior Vice President of Business Development and M&A at BeiGene, with over 20 years of experience in the biopharmaceutical industry.
Title
Clare Fisher holds the position of Senior Vice President of Business Development and M&A at BeiGene. She joined the company in July 2021 and works from Cambridge, Massachusetts, United States.
Company
Clare Fisher is currently employed at BeiGene, a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing innovative medicines. She joined BeiGene in July 2021 as the Senior Vice President of Business Development and M&A.
Education and Expertise
Clare Fisher earned her B.S. in Biochemistry from the University of Bath and later pursued an MBA at Henley Business School, graduating between 2002 and 2005. She has over 20 years of experience in business development and corporate strategy within the biopharmaceutical industry.
Background
Prior to joining BeiGene, Clare Fisher held various senior roles in business development and corporate strategy. She served as Chief Business Officer at Kaleido Biosciences, Corporate Development at Shire, and Business Development & Strategy at Genzyme and Blueprint Medicines. Fisher’s roles have taken her through significant tenures at renowned companies within the biopharmaceutical sector, contributing to her extensive experience.
Achievements
Clare Fisher’s tenure in the biopharmaceutical industry includes notable roles such as Chief Business Officer at Kaleido Biosciences and Group Vice President at Shire plc (now Takeda). With a background in biochemistry and an MBA, her contributions have significantly impacted corporate development and business strategies across various organizations.